AARCEE Adornation Limited Liability Company – Trademark Portfolio
Entity Type: 16
AARCEE Adornation Limited Liability Company holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 24 (Fabrics) across 7 Nice Classification classes. The owner is based in Newark, NJ.
c/o Meyner and Landis LLP
One Gateway Center, Suite 2500
Newark, NJ 07102
Showing of trademarks Trademarks
Trademark Classifications
AARCEE Adornation Limited Liability Company's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does AARCEE Adornation Limited Liability Company have?
AARCEE Adornation Limited Liability Company has 6 U.S. trademarks filed with the USPTO.
What trademark classes does AARCEE Adornation Limited Liability Company file in?
AARCEE Adornation Limited Liability Company files trademarks across 7 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 24 (Fabrics), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What is AARCEE Adornation Limited Liability Company's trademark registration success rate?
AARCEE Adornation Limited Liability Company has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.